Dalli LL, Olaiya MT, Kim J, Andrew NE, Cadilhac DA, Ung D, Lindley RI, Sanfilippo FM, Thrift AG, Nelson MR, Gall SL. Antihypertensive medication adherence and the risk of vascular events and falls after stroke: a real-world effectiveness study using linked registry data. Hypertension. 2023 Jan;80(1):182-91.

Andrew NE, Ung D, Olaiya MT, Dalli LL, Kim J, Churilov L, Sundararajan V, Thrift AG, Cadilhac DA, Nelson MR, Lannin NA. The population effect of a national policy to incentivize chronic disease management in primary care in stroke: a population-based cohort study using an emulated target trial approach. The Lancet Regional Health–Western Pacific. 2023 May 1;34. 

Hoarau D, Ramos I, Termoz A, Fernandez V, Rambure M, Allemann SS, Derex L, Haesebaert J, Schott AM, Viprey M. Determinants of adherence to post‐stroke/transient ischemic attack secondary prevention medications: A cohort study. European Journal of Neurology. 2024 Oct;31(10):e16395.

Tannous EE, Selitzky S, Vinker S, Stepensky D, Schwarzberg E. Predictive modelling of medication adherence in post-myocardial infarction patients: a Bayesian approach using beta-regression. European Journal of Preventive Cardiology. 2025 Jun;32(8):649-58.

Amiesimaka OI, Allemann SS, Braund R, Schultz M, Aluzaite K. Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis. British Journal of Clnical Pharmacology. 2024 Aug;90(8):1911-20.

Nelson T, Wilkie DJ, Yao Y, Segal R, DeVaughan-Circles A, Donahoo WT, Goins RT, Manson SM, Legaspi AB, Scarton L. Medication Engagement, Determinants of Health, and A1C Levels Among Adults With Type 2 Diabetes within a Tribal Health System. The science of diabetes self-management and care. 2024 Aug;50(4):275-86.